Boston University School of Medicine

Core curriculum

Online training


CME information


  Create an account or log in to participate in this activity

Partners

These activities were planned in collaboration with the Council of Medical Specialty Societies (CMSS), the Federation of State Medical Boards (FSMB), Med-IQ Inc., and the National Committee of Quality Assurance (NCQA).

Accreditation

Physicians

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

CNE Contact Hours: 2, all of which are pharmacology credit-worthy

Risk Management and Pain Management Credits

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study and opioid education. Several states have similar requirements. Please check with your Board to determine if this activity will fulfill your state's specific requirements.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for opioid education.

American Academy of Family Physicians (AAFP)

This Enduring Material activity, SCOPE of Pain: Safer/Competent Opioid Prescribing Education, has been reviewed and is acceptable for up to 2.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 02/28/2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate and de-identified data is shared with the commercial supporters.

American Board of Medical Specialties Maintenance of Certification Part 2 Credit

Through the American Board of Medical Specialties (ABMS) ongoing commitment to increase access to practice relevant Maintenance of Certification (MOC) Activities through the ABMS Continuing Certification Directory, SCOPE of Pain has met the requirements as an MOC Part II Self-Assessment and/or MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II Self-Assessment Activity
MOC Part II CME Activity

Note: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board's general CME requirement (only). Please refer directly to your Member Boards' MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

In order to receive credit, participants must review the activity content and complete the post-tests and evaluation for the two one-hour modules included within the activity. Participants who receive a cumulative grade of 70% or greater on the post-tests will receive credit. BOTH of the one-hour modules must be completed in order to earn your online certificate of credit. There will also be an online follow-up survey that will be distributed two months after completion of the program in order to further measure participant's changes in knowledge and behavior.

Date of Release: 3/1/19
Date of Expiration: 2/29/20

Target audience

Physicians, nurse practitioners, registered nurses, physician assistants, nurses, dentists, pharmacists, and allied health professionals whose practices manage acute and chronic pain.

Educational objectives

At the conclusion of these activities, participants will be better able to:

  1. Optimize safety when prescribing opioids for acute pain
  2. Determine when opioid analgesics are indicated for chronic pain
  3. Assess pain and prescription opioid misuse risk
  4. Educate patients about opioid risks and realistic benefits
  5. Monitor patients on opioid therapy for benefits and harms
  6. Assess and manage worrisome opioid-taking behaviors
  7. Safely taper long-term opioid therapy
  8. Identify and manage patients with an opioid use disorder

For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.

Disclosures

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Off-Label Discussion

This activity does include discussion of the off-label use of sublingual buprenorphine to treat pain. Sublingual buprenorphine has been FDA approved for addiction treatment but not pain treatment. This presentation does include discussion of the off-label use of clonidine and tizanidine to treat opioid withdrawal symptoms. Clonidine and tizanidine are not FDA approved for this use.

Faculty

Daniel P. Alford, MD, MPH, FACP
Course Director
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Jessica Taylor, MD
Assistant Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Planning Committee

Brian Jack, MD, independent AAFP reviewer
Ilana Hardesty, Senior Operations Manager, Boston University School of Medicine CME Office
Ms. Carmela Townsend, DNP, MS/MBA, RN, Lead Nurse Planner, Boston University School of Medicine CME Office
Kristin Wason, MSN, NP-C, CARN, CNE Course Advisor, Boston University School of Medicine CME Office
Jason Worcester, MD, independent CME reviewer
Stephen A. Wyatt, DO, independent CME reviewer

Planning Committee members have nothing to disclose with regard to commercial support.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

Disclosure of support

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration.

Boston University Council of Medical Specialty Societies Federation of State Medican Boards